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ABSTRACT
Background: Low-grade gliomas (LGG) are described by the World Health Organization as Grades I and II.
Among LGGs, the most common primary brain tumor is pilocytic astrocytoma (PA) and carries an excellent
prognosis when treated with complete surgical resection. Cases, in which this is not possible, are associated with
less favorable outcomes and worse progression-free survival.
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Case Description: This report describes a case of a 22-year-old male, who presented with progression of a
primary brainstem tumor previously treated with stereotactic radiosurgery and chemotherapy. Patient underwent
surgical exploration and was diagnosed with juvenile PA, but debulking was limited by the very dense and fibrous
tumor. Complete surgical resection was not possible at this time. Despite efforts to treat with chemotherapy, the
patient presented a year later with clinical deterioration and severe neurologic deficits, prompting surgical reexploration. During the second operation, the tumor was found to have undergone very significant softening in
consistency, allowing for gross total resection (GTR)
Conclusion: Aggressive treatment of brainstem LGG should be pursued whenever possible, given its generally
favorable prognosis. Repeat microsurgical resection, even with a different approach, might be reasonable and
safe. Finally, chemotherapy may be associated with changes in the tumor consistency that can render previously
unresectable lesions amenable to successful aggressive resection.
Keywords: Brainstem low-grade glioma, Chemotherapy, Gross total resection, Pilocytic astrocytoma, Tumor
consistency

INTRODUCTION
Low-grade gliomas (LGG) have been described according to the World Health Organization
(WHO), as Grades I and II.[7] Among these LGGs, the most common primary brain tumor is
PA, accounting for 5.1% of all primary brain and central nervous system gliomas, and are
described as relatively benign Grade I neoplasms.[7,9] It is the most prevalent primary brain
tumor among children age 0–19 years, representing 15.3% of all cases.[9] Among children age
0–14 years, PAs have an annual age-adjusted incidence rate of 1.01 (per 100,000) that significantly
decreases (0.28/100,000) in adolescents and young adults (age 15–30 years).[9] PAs in children
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most commonly occur in the cerebellum, optic pathway/
hypothalamic region, and supratentorial hemispheres but
less frequently may occur in the brainstem and spinal cord.[2]
PAs commonly arise sporadically but there is an increased
risk occurrence in the optic pathway in patients with
neurofibromatosis Type 1.[3]
PAs are typically well-defined tumors with cystic formation
occurring within the tumor or around the tumor with associated
solid nodule.[3] Histopathologically, PAs demonstrate a biphasic
growth pattern with areas of highly fibrillated cells mixed with
loose microcystic component accompanied by Rosenthal fibers
and eosinophilic granular bodies.[3] Microvascular proliferation
is common but does not indicate malignancy like in diffuse
high-grade gliomas.[3] Recently, genetic alterations in the
mitogen-activated protein kinase pathway of PAs have been
described in literature with the most common alteration being
a fusion between KIAA1549 and BRAF.[3]
While PAs are considered to have an excellent prognosis with
overall 10-year survival reported over 90%, tumors where
complete surgical resection is unable to be carried out have
less favorable progression-free survival (PFS) and overall
survival.[3,9] Primary treatment of these tumors is surgery,
but radiotherapy and chemotherapy may be indicated in
cases with incomplete resection or contraindication to
surgery.[3] Among reported brainstem LGGs treated with
surgical resection or chemotherapy, there is a clear positive
correlation with extent of surgical resection and PFS [Table 1].

For example, Ahmed et al. describes 21 patients who received
gross total resection (GTR) or subtotal resection (STR) with
5-year overall survival of 85%, while Klimo et al. reported 9
patients who received GTR with 5-year PFS at 75%.[1, 6]
However, the repeat microsurgical resection of partially
resected tumors that have been treated with chemotherapy
resulting in gross total resection (GTR) has not been
previously reported. Here, we present a case of a 22-year-old
male with an initially unresectable brainstem LGG treated
with vincristine and carboplatin, subsequently undergoing
changes in consistency allowing for GTR on repeat surgery.

CASE PRESENTATION
History
On March 2015, a 22-year-old right-handed male with a
2 month history of right sided weakness and numbness was
diagnosed with a primary brainstem tumor on MRI. He was
empirically treated with temozolomide, bevacizumab, and
stereotactic radiosurgery (SRS). Six months later, while stable
disease was noted on brain MRI, the patient was also treated
with an additional hypo-fractionated course (~50Gy in 25
fractions over 2 months) of involved field radiation.
Patient received empiric chemotherapy and radiation therapy
for 21 months and follow-up brain MRI on December
2016 revealed a stable, necrotic left midbrain mass lesion

Table 1: Summary of previously reported brainstem low-grade glioma managed with surgical resection or chemotherapy.
Citation

Patient Age

Surgical Resection

Chemotherapy

Outcomes

Upadhyaya
et al., 2017
Ronghe
et al., 2010
Kestle
et al., 2004

25 patients (median
age 6 years old)
16 patients (median
age 4.2 years old)
28 patients (median
age 7.8 years old)

GTR: 4 patients
NTR or less: 21 patients
Partial or STR: 14 patients

Adjuvant therapy: 10
patients
Vincristine and
Carboplatin: 16 patients
Adjuvant therapy: 2
patients

Lundar
et al., 2014

15 patients (median
age 6 years old)

GTR: 10 year PFS at 100% (4/4)
Entire cohort: 10 year PFS at 71%
Median follow-up of 57 months PFS at
68.75% (11/16)
GTR or resection with linear
enhancement: 5 year PFS at 74%
Solid residual tumor or biopsy: 5 year
PFS at 19%
Median follow up of 8 years with 80%
survival rate (12/15)

Ahmed
et al., 2014[1]

48 patients (median
age 12 years old)

Klimo et al.,
2013[6]

52 patients (median
age 6.5 years old)

GTR or resection with linear
enhancement: 12 patients
Solid residual tumor or
biopsy: 16 patients
Primary tumor resection: 15
patients
Repeat resection: 6 patients
GTR: 4 patients
STR: 17 patients
Biopsy: 27 patients

GTR: 9 patients
NTR: 17 patients
STR: 9 patients
Biopsy: 17 patients

Adjuvant therapy: 4
patients
Procarbazine,
Lomustine, and
Vincristine: 6 patients
Post-operative
radiotherapy: 29
patients
Adjuvant chemo
and radiotherapy: 27
patients

GTR: Gross total resection, PFS: Progression-free survival, NTR: Near total resection, STR: Subtotal resection
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Median follow-up of 6 years
GTR or STR: 5-year overall survival
85%
Biopsy: 5-year overall survival 50%
Entire cohort: 5-year overall survival
67%
GTR: 5-year PFS at 75%
NTR: 5-year PFS at 25.7%
STR: 5-year PFS at 33.3%
Entire cohort: 5-year overall survival
98%
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measuring 2.5 × 2.1 × 1.8 cm with subacute hemorrhage in
the inferior posterior margin [Figure 1].
Nearly 2 years after the initial diagnosis, the patient presented
to the clinic with progressively worsening gait instability
and left greater than right weakness. Additional symptoms
included transient confusion with malaise and dizziness.
Brain MRI at this time revealed progression at medial and
inferior margins along with interval mild ventriculomegaly
consistent with obstructive hydrocephalus [Figure 2].
Decision was made to place the shunt and resect the tumor in
a two-stage procedure during the same admission.
First operation – VP shunt placement and partial tumor
resection/biopsy
The patient underwent an uneventful right occipital
ventriculoperitoneal shunt placement with utilization of
volumetric image guidance and laparoscopic assistance.

a

The following day, left posterior temporal-occipital craniotomy
was performed with an intention to obtain tissue for diagnosis
and remove as much of the brainstem tumor as safely as possible.
Volumetric image guidance, microscope, neuro-monitoring,
and intraoperative MRI were utilized. The brainstem lesion
was approached through the posterior temporal-occipital
supratentorial plane with sectioning of the tentorium to widen
the exposure. The inferior posterior temporal gyrus was
partially resected, allowing mobilization and preservation of
the vein of Labbe. The midbrain was entered through the lateral
mesencephalic safe entry zone. The tumor itself was very firm
and moderately vascular. Usual microsurgical tools, including
ultrasonic aspirator, were inefficient.
The tumor’s firm consistency did not allow us to remove
much of the lesion. The outer portions of the mass were
very fibrous and could not be mobilized. Progress was
very slow. The remaining tumor was “hard as a rock” in
consistency, and surgical manipulation would move it as a

c

b

Figure 1: Initial brain MRI: (a) Axial T1 image with contrast; (b) coronal FLAIR and (c) coronal T1 with contrast images, showing large left
midbrain-pontine lesion at the time of stereotactic radiosurgery.

a

b

c

Figure 2: Two years after stereotactic radiosurgery and first round of chemotherapy: (a) Brain CT showing hemorrhage in the dorsal aspect
of the tumor. Brain MRI with contrast: (b) Axial T1 image demonstrating the lesion in the left brainstem and prominent temporal horns
(arrows), suggestive of an obstructive hydrocephalus; (c) sagittal T1 image showing ring-enhancing mass.
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single block, distorting the entire brainstem. Considering the
circumstances, it was felt that the safest choice would be to
stop further dissection/tumor removal. Intraoperative MRI
showed an approximately 40% decrease in tumor volume, but
the peripherally enhancing capsule of the tumor remained
unchanged, as expected given the consistency of the tumor
encountered intraoperatively [Figure 3].

weakness to 1–2/5, hypophonia, and rapidly progressing
functional decline. Brain CT showed known mass extending
from the brainstem to the thalamus, slightly eccentric on the
left. A hemorrhagic component within the mass and slight
increase in size of the tumor was noted as well [Figure 4].

Pathology and postoperative course

The patient underwent suboccipital-torcular craniotomy
with utilization of volumetric image guidance, microscope,
and neuromonitoring. The lesion was approached through
the supracerebellar infratentorial corridor through the
infracollicular safe entry zone. Initially, the cystic portion was
decompressed and motor oil-like fluid evacuated. The cyst
walls collapsed and the brainstem relaxed. The solid portion
of the tumor in the middle of the caudal midbrain and upper
pons was considerably softer than in the first surgery, but
more vascular with areas of hemorrhagic transformation. This

Final pathology confirmed PA, negative for BRAF mutation
or rearrangement, and the patient was started on combination
therapy with carboplatin and vincristine. Unfortunately,
chemotherapy was complicated with breakthrough seizures
and brain MRI revealed symptomatic interval progression
of the left midbrain tumor. Carboplatin and vincristine were
discontinued, and seizures controlled with levetiracetam,
gabapentin, and valproic acid. The patient was subsequently
started on a 3 day monthly cycle of cisplatin and etoposide.

Second operation

On May 2018, 14 months after the first operation, the patient
presented to the emergency department for worsening
headache, double vision, right-sided weakness, and gait ataxia.
Clinically, he was noted to have significant right upper extremity

a

c

a

b

c

d

b

d

Figure 3: MRI images with contrast: (a) Immediate preoperative
axial T1 views; (b) intraoperative Axial T1 views demonstrate
an approximate 40% resection of the lesion (dotted arrow) and
expected intraoperative pneumocephalus (solid arrows); (c)
immediate preoperative coronal T1 views; (d) intraoperative
coronal T1 views.
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Figure 4: Four months after partial resection and shunting;
(a) non-contrast brain CT shows hemorrhagic component
mostly in the posterior aspect of the tumor; (b) axial,
(c) sagittal, and (d) coronal T1 MRI views with contrast,
showing significant interval tumor enlargement with solid
(solid arrows) and cystic (dotted arrows) components.
At this point in the patient’s care, it was felt, he did not have many
options left. He appeared to have either poorly tolerated, or did not
respond to, chemotherapy. After two prior radiation treatments, he
was ineligible for further radiation. Therefore, a multi-disciplinary
decision was made to repeat neurosurgical intervention in an attempt
to decompress the cyst and remove some more tumor, if feasible.
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tumor was successfully mobilized and grossly resected with
what appeared to be normal appearing brainstem underneath.
Postoperative brain MRI demonstrated GTR and marked
decompression of the brainstem. Pathology confirmed
mainly necrosis and hemorrhage with focal residual PA
with little/no proliferation and Ki-67 in MID1 proliferation
indices [Figure 5].
Postoperative complications
Five days after surgery, the patient experienced increased
somnolence. Head CT revealed new bilateral parietooccipital subdural and epidural retrocerebellar hemorrhage.
The parieto-occipital convexity hemorrhages were
likely related to intra- and postoperative brain shift and
tearing of the bridging veins. Although supratentorial
hematomas were not felt to require surgical intervention,
the retrocerebellar hemorrhage was more significant. The
patient was subsequently taken up for emergent re-opening
of the torcular-suboccipital craniotomy for evacuation of the
epidural hematoma. Postoperative CT revealed successful
evacuation of the extra-axial hematoma.

neoplasm.[7] The most common clinical presentation of
brainstem PA is a focal neurological deficit of cranial nerves
corresponding to the anatomical location of the tumor with
or without involvement of the motor/sensory long tracts.[2]
Additional symptoms of hydrocephalus and headache may
be present as well.[2] While PAs are considered to have an
excellent prognosis with overall 10-year survival reported
over 90%, tumors where complete surgical resection is
unable to be carried out have less favorable PFS and overall
survival.[3,9] In addition, brainstem PA is complicated with
significant neurological morbidity secondary to their
location.[11]
The gold standard for approaching pediatric brainstem LGGs
is initial treatment with safe maximal surgical resection, in
conjunction with chemotherapy and radiation therapy as
needed.[11] Upadhyaya et al. studied 25 cases of pediatric
non tectal brainstem LGGs treated with surgical resection.
All three patients with GTR and histological diagnosis of PA
demonstrated no evidence of disease at long-term followup.[11] Overall, the study found a 10-year PFS rate of 71% in
these 25 patients, of which 16 were cases of brainstem PA.[11]

DISCUSSION

Kestle et al.’s study investigated 28 cases of pediatric
brainstem PA, of which 25 were treated with neurosurgical
resection.[5] Kestle et al.’s study found a direct correlation
between extent of tumor resection and long-term survival.[5]
Twelve patients had postoperative imaging demonstrating
GTR or linear enhancement, with a 10-year PFS of 62%. In
contrast, the 13 patients with postoperative scans revealing
residual solid tumor only had a 10-year PFE of 19%.[5] While
patients with GTR saw long-term PFS, surgical resection
was often associated with neurological dysfunction most
apparent in the immediate postoperative phase.[5] This deficit
typically resolved but persisted in 6 of the 28 patients.[5]

LGG have been described according to the WHO, as Grades
I and II.[7] Among these LGGs, the most common primary
brain tumor is PA described as a relatively benign Grade I

While GTR of brainstem PA clearly leads to favorable
outcomes, adjuvant or neoadjuvant radiation therapy may
also be used in the management of these tumors. Gagliardi

Three months after surgery, follow-up brain MRI
demonstrated evolving postoperative changes with no
residual/recurrent tumor.
Twelve months after surgery, the patient’s dysarthria
improved. Motor exam revealed persistent right hemiparesis
(improved to 3–4/5), arm weaker than the leg. Patient was
now able to stand and walk short distances with assistance.
Chronic steroids have been successfully weaned off, and the
patient had a complete reversal of cushingoid appearance.

a

b

c

Figure 5: Postoperative brain MRI: (a) Axial T1 image; (b) sagittal T1 image; and (c) coronal T1 image, demonstrating postsurgical changes
after GTR of the left dorsal midbrain-pontine tumor.
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et al. investigated the use of radiotherapy for LGGs in 39
patients.[4] Of these, four solid lesions converted into mixed
tumors following GKRS.[4] In addition, tumor progression
was followed in patients and found cyst progression occurred
more commonly in patients with a mixed lesion at the time
of radiation therapy.[4] Four of five reported incidents of cyst
progression were found to be PA.[4] Overall, this study found
a 10-year PFS rate of 39.1% in those treated with Gamma
Knife Radiosurgery.[4]
The patient in this case report was not offered surgery as
the first line of treatment. Instead, he was treated with
SRS, another hypofractionated course of radiotherapy,
and chemotherapy. It is conceivable that the tumor could
acquire its very firm consistency as a consequence of these
treatments. Hardening of the tumor due to radiation therapy
is a well described phenomenon.[10] Multiple authors reported
surgical challenges associated with resection of previously
irradiated tumors. Changes in the tumor consistency might
be related to the development of fibrosis within the tumor
and excessive perifocal scarring. Such changes were noted
during the first surgery. However, the second round of
chemotherapy with carboplatin and vincristine, along with
another cycle with cisplatin and etoposide, was associated
with considerable softening of the tumor and its partial
hemorrhagic transformation that allowed for gross resection.
This phenomenon has not been previously described in the
literature. It could be also suggested that between [Figures 3
and 4], a newly enhancing tissue (best seen on the axial and
coronal MR images) may represent a growth of radiotherapynaïve tumor, which was softer and thus, more amenable to
surgical resection. This hypothesis can be true only if the
surgeons did not leave behind a considerable amount of solid
tissue after the first surgical procedure, which was not the
case. In addition, the tumor, new or old, could outgrow its
blood supply and undergo necrotic transformation, which
could also be influenced by chemotherapy. It is important to
note, though, that the new radiotherapy-naïve component
was exposed to chemotherapy, much like the hard tumor
treated with XRT. At this point, we can only speculate about
the extent to which the above potential mechanisms could
have contributed to the apparent softening of the mass.
Although not unequivocally proving the exact causality,
the facts that remain clear are (1) very hard consistency of
the tumor discovered on the first surgery and (2) a quite
significant softening of previously unresectable lesion
after chemotherapy. Therefore, the authors believe that
chemotherapy could have contributed to the success of the
second surgery.
We did not find any reports of repeat surgical interventions
on adult patients with brainstem LGG. One study reported 12
pediatric patients with midbrain LGG who were treated with
multiple repeat tumor resections due to disease progression
with seemingly stable long-term results obtained in at least
Surgical Neurology International • 2021 • 12(12)
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nine patients.[8] The surgeons treating brainstem LGG should
be aware of possibility of chemotherapy induced tumor
softening phenomenon and be prepared to offer repeat
surgery, even if the lesion was initially deemed unresectable.

CONCLUSION
Aggressive treatment of brainstem LGG should be
pursued whenever possible, given its generally favorable
prognosis. Repeat microsurgical resection, even with a
different approach, might be reasonable and safe. Finally,
chemotherapy may be associated with changes in the tumor
consistency that can render previously unresectable lesions
amenable to successful aggressive resection.
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